LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.

Amanda E D Van SwearingenMarni B SiegelAllison M DealMaria J SambadeAlan HoyleD Neil HayesHeejoon JoPaul LittleElizabeth Claire DeesHyman MussTrevor JollyTimothy M ZagarNirali PatelC Ryan MillerJoel S ParkerJ Keith SmithJulie FisherNikita ShahLisle NabellRita NandaPatrick DillonVandana AbramsonLisa A CareyCarey K Anders

Published in: Breast cancer research and treatment (2018)

(NCT01305941).

Keyphrases

phase ii study
positive breast cancer
brain metastases
small cell lung cancer
multiple sclerosis
epidermal growth factor receptor
open label
locally advanced
metastatic breast cancer
placebo controlled
squamous cell carcinoma
rectal cancer
tyrosine kinase
clinical trial